Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study

In conclusion, risk factors that may impact treatment with oral Janus kinase inhibitors were frequent in Danish adults with atopic dermatitis, especially among older individuals. Dermatologists need support and continuously updated long-term safety data when risk-evaluating patients with atopic dermatitis prior to initiation of advanced.PMID:38248914 | PMC:PMC10811548 | DOI:10.2340/actadv.v104.18638

Source: Acta Dermato-Venereologica - January 22, 2024 Category: Dermatology Authors: Ida Vittrup David Thein Simon Francis Thomsen Alexander Egeberg Jacob P Thyssen Source Type: research